16523-02-7 Usage
Description
2-BROMOETYL-METHYLSULFONE, also known as 2-Bromoethyl Methyl Sulfone, is an organic compound that serves as a reagent in the synthesis of various chemical compounds. It possesses a unique structure with a bromine atom attached to an ethyl group, which is connected to a methylsulfone group. This structure endows it with specific chemical properties that make it useful in a variety of applications.
Uses
Used in Electrochemical Applications:
2-BROMOETYL-METHYLSULFONE is used as a reagent for the preparation of sulfone-functionalized imidazolium ionic liquid electrolytes. These electrolytes exhibit interesting electrochemical properties, making them suitable for use in various electrochemical devices and systems.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2-BROMOETYL-METHYLSULFONE is utilized as a building block or intermediate in the synthesis of a wide range of chemical compounds. Its unique structure allows it to participate in various chemical reactions, contributing to the formation of desired products.
Used in Pharmaceutical Industry:
2-BROMOETYL-METHYLSULFONE may also find applications in the pharmaceutical industry, where it can be used as a starting material or intermediate in the synthesis of drug candidates. Its chemical properties can be harnessed to develop new drugs with potential therapeutic benefits.
Used in Material Science:
In the realm of material science, 2-BROMOETYL-METHYLSULFONE can be employed in the development of novel materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of materials with improved characteristics, such as enhanced stability, solubility, or reactivity.
Overall, 2-BROMOETYL-METHYLSULFONE is a versatile reagent with a broad range of applications across different industries, including electrochemistry, chemical synthesis, pharmaceuticals, and material science. Its unique structure and chemical properties make it a valuable component in the development of new technologies and products.
Check Digit Verification of cas no
The CAS Registry Mumber 16523-02-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,5,2 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 16523-02:
(7*1)+(6*6)+(5*5)+(4*2)+(3*3)+(2*0)+(1*2)=87
87 % 10 = 7
So 16523-02-7 is a valid CAS Registry Number.
16523-02-7Relevant articles and documents
Synthesis and electrochemical property of sulfone-functionalized imidazolium ionic liquid electrolytes
Weng, Wei,Zhang, Zhengcheng,Schlueter, John A.,Amine, Khalil
, p. 392 - 396 (2013)
Sulfone-functionalized imidazolium ionic liquids were synthesized from direct nucleophilic substitution for the first time. Detailed NMR analysis of the products revealed the competition pathways of classic SN2 substitution and E2 elimination i
Compounds, liquid crystal composition, liquid crystal display element and liquid crystal display
-
Paragraph 0148; 0159; 0160; 0161, (2020/02/27)
The invention relates to compounds, a liquid crystal composition, a liquid crystal display element and a liquid crystal display. The compounds are represented by a formula I shown in the description.The liquid crystal composition provided by the invention
ARYLOXYACETYLINDOLES AND ANALOGS AS ANTIBIOTIC TOLERANCE INHIBITORS
-
Paragraph 0729, (2016/08/10)
The disclosure provides compounds and pharmaceutical compositions of aryloxyacetylindoles compounds and analogs useful for treating chronic and acute bacterial infections. Certain of the compounds are compounds of general Formula (I) (I) or a pharmaceutically acceptable salt or prodrug thereof. Certain compounds of this disclosure are MvfR inhibitors. MvfR inhibitors reduce the formation of antibiotic tolerant bacterial strains and are useful for treating Gram-negative bacterial infections and reducing the virulence of Pseudomonas aeruginosa. Methods of treating bacterial infections in a subject, including Pseudomonas aeruginosa infections, are also provided by the disclosure.
